Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2016
  • IPO: 2021

• Founders

  • Chris Gibson, PhD
  • Blake Borgeson, PhD
  • Dean Li, PhD

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • We’re hiring! Recursion is seeking a Director of Business Process Management to design and execute processes that w… https://t.co/BAzdltH21D@RecursionPharma - 03:10 PM May 4th
  • Recursion’s Innovation and Scale Up Team is hiring a Process Development Research Scientist. This role will support… https://t.co/XODeZvilij@RecursionPharma - 03:22 PM Apr 29th
  • Recursion is seeking an experienced Medical Writer to join our growing team. This role will support our Clinical Op… https://t.co/nZrWJb54Mn@RecursionPharma - 03:10 PM Apr 27th